Discover

GRI
GRI Bio, Inc.
2.12
1 x 2.06
5 x 2.07
bid
ask
+
0.42
24.87%
01:40 PM
timesize
Ytd-69.32%
1y-93.49%
1.75
day range
2.55
1.36
52 week range
80.36
Open1.86Prev Close1.70Low1.75High2.55Mkt Cap187.30K
Vol5.96MAvg Vol65.74KEPS-52.02P/E-0.04Forward P/E-0.29
Beta-1.21Short Ratio0.10Inst. Own4.71%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg1.79200-d Avg11.701yr Est11.50
Income Statement
Operating Expenses2.00M
Research and Development Expense361.00K
Selling, General and Administrative Expense1.64M
Operating Income-2.00M
Net Income-2.00M
Net Income Common Stock-2.00M
Net Income Common Stock (USD)-2.00M
Consolidated Income-2.00M
Earnings per Basic Share-1.61
Earnings per Basic Share (USD)-1.61
Earnings per Diluted Share-1.61
Earning Before Interest & Taxes (EBIT)-2.00M
Earning Before Interest & Taxes (USD)-2.00M
Weighted Average Shares1.24M
Weighted Average Shares Diluted1.24M
Balance Sheet
Cash and Equivalents11.05M
Cash and Equivalents (USD)11.05M
Current Assets11.28M
Property, Plant & Equipment Net60.00K
Total Assets11.34M
Debt Current58.00K
Total Debt58.00K
Current Liabilities794.00K
Total Liabilities794.00K
Accumulated Retained Earnings (Deficit)-53.69M
Shareholders Equity10.55M
Shareholders Equity (USD)10.55M
Assets Non-Current60.00K
Total Debt (USD)58.00K
Trade and Non-Trade Payables303.00K
Cash Flow
Depreciation, Amortization & Accretion1000
Net Cash Flow from Financing6.50M
Net Cash Flow / Change in Cash & Cash Equivalents2.82M
Issuance (Purchase) of Equity Shares6.50M
Net Cash Flow from Operations-3.68M
Share Based Compensation31.00K